Luigi Bartalena

Summary

Country: Italy

Publications

  1. ncbi Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge
    Luigi Bartalena
    University of Insubria, Varese, Italy
    Clin Endocrinol (Oxf) 56:23-4. 2002
  2. ncbi An update on medical management of Graves' ophthalmopathy
    L Bartalena
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    J Endocrinol Invest 28:469-78. 2005
  3. ncbi Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?
    Maria Laura Tanda
    Division of Endocrinology, Department of Clinical Medicine, University of Insubria, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    Eur J Endocrinol 159:359-61. 2008
  4. doi Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    Thyroid 18:333-46. 2008
  5. doi Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, 21100 Varese, Italy
    Eur J Endocrinol 158:273-85. 2008
  6. ncbi Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications
    Luigi Bartalena
    Division of Endocrinology, University of Insubria, Varese, Italy
    Biofactors 19:155-63. 2003
  7. ncbi Relationship between management of hyperthyroidism and course of the ophthalmopathy
    L Bartalena
    Department of Clinical Medicine, Division of Endocrinology, University of Insubria, Varese, Italy
    J Endocrinol Invest 27:288-94. 2004
  8. ncbi Graves' ophthalmopathy: state of the art and perspectives
    L Bartalena
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    J Endocrinol Invest 27:295-301. 2004
  9. ncbi The role of somatostatin analogs in the management of Graves' ophthalmopathy
    L Bartalena
    Division of Endocrinology, University of Insubria, Varese, Italy
    J Endocrinol Invest 26:109-13. 2003
  10. ncbi Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association
    Luigi Bartalena
    Division of Endocrinology, University of Insubria, Varese, Italy
    Clin Endocrinol (Oxf) 61:494-502. 2004

Detail Information

Publications66

  1. ncbi Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge
    Luigi Bartalena
    University of Insubria, Varese, Italy
    Clin Endocrinol (Oxf) 56:23-4. 2002
  2. ncbi An update on medical management of Graves' ophthalmopathy
    L Bartalena
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    J Endocrinol Invest 28:469-78. 2005
    ..Antioxidants might have a role, at least in mild forms of GO. Particular attention should be paid to correction of risk factors (cigarette smoking, thyroid dysfunction, radioiodine therapy) involved in GO progression...
  3. ncbi Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?
    Maria Laura Tanda
    Division of Endocrinology, Department of Clinical Medicine, University of Insubria, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    Eur J Endocrinol 159:359-61. 2008
  4. doi Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    Thyroid 18:333-46. 2008
  5. doi Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, 21100 Varese, Italy
    Eur J Endocrinol 158:273-85. 2008
  6. ncbi Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications
    Luigi Bartalena
    Division of Endocrinology, University of Insubria, Varese, Italy
    Biofactors 19:155-63. 2003
    ..It currently seems unlikely that they may find a relevant place in the limited armamentarium available for the management of severe GO...
  7. ncbi Relationship between management of hyperthyroidism and course of the ophthalmopathy
    L Bartalena
    Department of Clinical Medicine, Division of Endocrinology, University of Insubria, Varese, Italy
    J Endocrinol Invest 27:288-94. 2004
    ..The authors' preference goes to the former, because it depletes intrathyroidal autoreactive T lymphocytes and removes thyroid antigens, which are likely to be involved in the pathogenesis of autoimmune reactions of the ophthalmopathy...
  8. ncbi Graves' ophthalmopathy: state of the art and perspectives
    L Bartalena
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    J Endocrinol Invest 27:295-301. 2004
    ..Cessation of smoking currently represents the only form of GO (secondary and tertiary) prevention...
  9. ncbi The role of somatostatin analogs in the management of Graves' ophthalmopathy
    L Bartalena
    Division of Endocrinology, University of Insubria, Varese, Italy
    J Endocrinol Invest 26:109-13. 2003
  10. ncbi Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association
    Luigi Bartalena
    Division of Endocrinology, University of Insubria, Varese, Italy
    Clin Endocrinol (Oxf) 61:494-502. 2004
    ..To determine how expert European thyroidologists assess and treat amiodarone-induced thyrotoxicosis (AIT)...
  11. ncbi An update on the pharmacological management of hyperthyroidism due to Graves' disease
    Luigi Bartalena
    Division of Endocrinology, Department of Clinical Medicine, Ospedale di Circolo, University of Insubria, Viale Borri, 57, 21100 Varese, Italy
    Expert Opin Pharmacother 6:851-61. 2005
    ..Neither one has clear advantages in terms of outcome but the latter method is associated with more frequent side effects. Hyperthyroidism relapses in approximately 50% of patients, to whom ablative therapy should be offered...
  12. ncbi Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    Eur J Endocrinol 153:13-4. 2005
  13. ncbi Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying
    L Bartalena
    Section of Endocrinology, Department of Clinical Medicine, University of Insubria, Varese, Italy
    J Endocrinol Invest 29:1012-6. 2006
  14. doi Novel immunomodulating agents for Graves orbitopathy
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Varese, Italy
    Ophthal Plast Reconstr Surg 24:251-6. 2008
  15. ncbi Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?
    L Bartalena
    Department of Endocrinology, University of Insubria, Varese, Italy
    J Endocrinol Invest 26:5-16. 2003
    ..It is recommended that a large, multi-center, prospective, randomized and controlled study with well defined inclusion criteria be carried out to draw sound conclusions on the role of OR in the management of Graves' ophthalmopathy...
  16. ncbi Orbital radiotherapy for Graves' ophthalmopathy
    Luigi Bartalena
    Cattedra di Endocrinologia, University of Insubria, Varese, Italy
    Thyroid 12:245-50. 2002
    ..g., in patients with diabetes) is a contraindication to this treatment for the risk of further retinal damage. No case of radiation-induced tumors has so far been described after orbital radiotherapy for Graves' ophthalmopathy...
  17. ncbi Perspectives in pharmacological management of Graves' hyperthyroidism and orbitopathy
    Luigi Bartalena
    Professor, Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    Expert Rev Clin Immunol 4:321-9. 2008
    ....
  18. ncbi Graves' ophthalmopathy: a preventable disease?
    Luigi Bartalena
    Cattedra di Endocrinologia, University of Insubria, Varese, Italy
    Eur J Endocrinol 146:457-61. 2002
    ....
  19. ncbi Management of thyroid eye disease
    Luigi Bartalena
    Department of Endocrinology, University of Insubria, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    Eur J Nucl Med Mol Imaging 29:S458-65. 2002
    ..A coordinated approach to the treatment of hyperthyroidism and TED is also required. Novel promising treatments, to be verified in large series of patients, include somatostatin analogues and cytokine antagonists...
  20. doi Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study
    Adriana Lai
    Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    J Clin Endocrinol Metab 95:1333-7. 2010
    ..2 mg/kg bw) are as effective as previously reported doses (0.3-0.5 mg/kg bw). A shorter treatment period (6 wk) is probably sufficient. The increase in bw is less using lower doses of prednisone...
  21. ncbi Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids
    Francesca Menconi
    Department of Endocrinology, University of Pisa, Via Paradisa 2, 56100 Pisa, Italy
    J Clin Endocrinol Metab 92:1653-8. 2007
    ..Total thyroid ablation (TTA) may be beneficial for GO through removal of shared antigen(s) and autoreactive T-lymphocytes, but randomized studies are lacking...
  22. doi Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists
    Maria Laura Tanda
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    Clin Endocrinol (Oxf) 69:812-8. 2008
    ..To investigate how North American thyroidologists assess and treat amiodarone-induced thyrotoxicosis (AIT) and to compare the results with those of the same questionnaire-based survey previously carried out among European thyroidologists...
  23. ncbi Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations
    Fausto Bogazzi
    Department of Endocrinology, University of Pisa, Ospedale Cisanello, Via Paradisa, 2, 56124 Pisa, Italy
    J Clin Endocrinol Metab 92:556-62. 2007
    ..Amiodarone-induced thyrotoxicosis (AIT) resulting from destructive thyroiditis (type 2) is commonly treated with glucocorticoids, but time needed to restore euthyroidism may be unacceptable for patients with underlying cardiac disorders...
  24. ncbi Novel treatment modalities for Graves' orbitopathy
    Luigi Bartalena
    Departments of Clinical Medicine and Surgical Sciences, University of Insubria, Division of Endocrinology, Varese, Italy
    Pediatr Endocrinol Rev 7:210-6. 2010
    ..However, randomized, controlled clinical trials to support their use are warranted...
  25. ncbi Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment
    Luigina Guasti
    Department of Clinical Medicine, University of Insubria, Varese, Italy
    Clin J Pain 23:518-23. 2007
    ..Moreover, a few experimental studies show that peripheral benzodiazepine receptors (PBRs), which may be altered in hypothyroidism, seem to be related with pain perception...
  26. doi Approach to the patient with amiodarone-induced thyrotoxicosis
    Fausto Bogazzi
    Department of Endocrinology, University of Pisa, Ospedale Cisanello, Via Paradisa, 2, 56124 Pisa, Italy
    J Clin Endocrinol Metab 95:2529-35. 2010
    ..RAI is usually not feasible in AIT due to low RAI uptake values. Thyroidectomy represents a valid option in cases resistant to medical therapy...
  27. doi Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study
    Gianlorenzo Dionigi
    Endocrine Surgery Research Center, Department of Surgical Sciences, University of Insubria, Varese, Italy
    Am J Surg 197:434-8. 2009
    ..The aim of the current study was to evaluate the time interval (TI) required for the diagnosis of symptomatic papillary thyroid carcinoma (PTC)...
  28. ncbi Medullary thyroid carcinoma: surgical treatment advances
    Gianlorenzo Dionigi
    Department of Surgical Sciences, University of Insubria, Azienda Ospedaliero Universitario, Fondazione Macchi 57, Varese, Italy
    Expert Rev Anticancer Ther 7:877-85. 2007
    ..We discuss the particular ethical and legal issues that thyroid prophylactic surgery raises. Searches were last updated in February 2007...
  29. ncbi Shortening hospital stay for thyroid surgery
    Gianlorenzo Dionigi
    Department of Surgical Sciences, Medical School, University of Insubria, Italy
    Expert Rev Med Devices 5:85-96. 2008
    ..We discuss the special ethical and legal issues that this thyroid surgery raises. Searches were last updated in May 2007...
  30. doi Nodule size and fine-needle aspiration biopsy: diagnostic challenges for thyroid malignancy
    Stefano Rausei
    Department of Surgical Sciences, University of Insubria, Borri, Italian Republic, Varese, Italy
    Am J Surg 201:525-30. 2011
    ..To investigate the relationship between nodule size and malignancy and the correlation between the dimensional parameter and fine-needle aspiration biopsy (FNAB) in patients with a nodular goiter...
  31. pmc Simultaneous medullary and papillary thyroid cancer: two case reports
    Gianlorenzo Dionigi
    Department of Surgical Sciences, University of Insubria, Varese, Italy
    J Med Case Reports 1:133. 2007
    ..Papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) have always been considered different from each other; in their incidence, their cell origin and their histopathological features...
  32. doi Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature
    Luca Tomisti
    Department of Clinical and Experimental Medicine, Section of Endocrinology, University of Pisa, Pisa, Italy
    Endocr Pract 19:1043-9. 2013
    ..To review the literature regarding the interaction among amiodarone therapy, thyroid hormone levels, and warfarin metabolism...
  33. doi The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, Endocrinology Unit, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    J Clin Endocrinol Metab 96:592-9. 2011
    ..Whether antithyroid drugs (ATDs), radioactive iodine (RAI), or thyroidectomy should be the treatment of choice in the presence of overt and active GO is a matter of debate...
  34. ncbi Long-term safety of orbital radiotherapy for Graves' ophthalmopathy
    Claudio Marcocci
    Department of Endocrinology, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 88:3561-6. 2003
    ..Although no secondary tumors were detected, due to the long latency of radiation-induced tumors, OR should be restricted to patients older than 35 yr...
  35. doi Prevention of Graves' ophthalmopathy
    Luigi Bartalena
    Department of Clinical and Experimental Medicine, University of Insubria, Endocrine Unit, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    Best Pract Res Clin Endocrinol Metab 26:371-9. 2012
    ..If radioiodine is used, low-dose steroid prophylaxis is recommended, particularly in smokers, to prevent radioiodine-associated GO progression...
  36. doi What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
    Luigi Bartalena
    Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Varese, Italy
    Clin Endocrinol (Oxf) 73:149-52. 2010
    ..The use of biological agents, the most promising being rituximab, is for the time being experimental and warrants support from randomized clinical trials...
  37. doi Efficacy and safety of orbital radiotherapy for graves' orbitopathy
    Maria Laura Tanda
    Department of Clinical, Experimental Medicine, University of Insubria, Endocrine Unit, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
    J Clin Endocrinol Metab 97:3857-65. 2012
    ..High-dose glucocorticoids (GCs) represent the first-line treatment. Orbital radiotherapy (OR) has been used for decades, alone or in combination with GCs, but opinions on its efficacy are conflicting...
  38. ncbi Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy
    Franca Marino
    Department of Clinical Medicine, Section of Experimental and Clinical Pharmacology, University of Insubria, Via Ottorino Rossi n 9, 21100 Varese VA, Italy
    Life Sci 78:1071-7. 2006
    ..The present results document the existence of a correlation between thyroid status and oxidative metabolism of human PMNs, which is however unlikely to depend upon a direct action of thyroid hormones on these cells...
  39. ncbi Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study
    Alessandro Squizzato
    Department of Clinical Medicine, University of Insubria, Ospedale di Circolo, Viale Borri 57, 21100 Varese, Italy
    Thromb Haemost 97:803-6. 2007
    ..The results of this pilot study suggest an increased prevalence of subclinical hypothyroidism in patients with unDVT. The clinical relevance of these preliminary findings needs to be addressed in larger prospective studies...
  40. doi A teleconsultation network improves the efficacy of anti-VEGF therapy in retinal diseases
    Claudio Azzolini
    Department of Surgical and Morphological Sciences, Section of Ophthalmology, University of Insubria, Ospedale di Circolo, Varese, Italy
    J Telemed Telecare 19:437-42. 2013
    ..27 logMAR; P > 0.05). The telemedicine network allows regional ophthalmologists to quantify the risk of disease progression, and to send patients to a Retina Centre quickly and easily, when required. ..
  41. ncbi Surgery of lymph nodes in papillary thyroid cancer
    Gianlorenzo Dionigi
    Department of Surgical Sciences, Medical School, University of Insubria, Viale Borri 57, 21100, Varese, Italy
    Expert Rev Anticancer Ther 6:1217-29. 2006
    ..This paper reviews relevant medical literature published in the English language on surgery of lymph nodes in differentiated thyroid cancer with well-controlled trials. Searches were last updated in June 2006...
  42. ncbi Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease
    Fausto Bogazzi
    Department of Endocrinology, University of Pisa, Italy
    Clin Endocrinol (Oxf) 66:7-12. 2007
    ..Peroxisome proliferators-activated receptor (PPAR)gamma is the master regulator of adipogenesis; however, the expression of PPARgamma isoforms in the subcutaneous adipose tissue (SAT) of patients with Cushing's disease is unknown...
  43. ncbi Treatment with thionamides before radioiodine therapy for hyperthyroidism: yes or no?
    Luigi Bartalena
    J Clin Endocrinol Metab 90:1256; author reply 1256-7. 2005
  44. ncbi Thyroid vascularity is increased in patients with active acromegaly
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Italy
    Clin Endocrinol (Oxf) 57:65-70. 2002
    ..To determine whether acromegalic patients have increased thyroidal vascularity and blood flow on colour flow Doppler sonography (CFDS)...
  45. ncbi Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 87:4490-5. 2002
    ..Accordingly, a short course of lithium therapy can be considered a useful adjunct to RAI therapy to obtain a prompter control of thyrotoxicosis and avoid its transient exacerbation because of MMI withdrawal and RAI administration...
  46. ncbi Current medical management of Graves ophthalmopathy
    Claudio Marcocci
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
    Ophthal Plast Reconstr Surg 18:402-8. 2002
  47. ncbi Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey
    Leandro Arthur Diehl
    Londrina State University, Brazil
    Clin Endocrinol (Oxf) 65:433-8. 2006
    ..To assess diagnostic and therapeutic approaches to amiodarone-induced thyrotoxicosis (AIT) among members of the Latin American Thyroid Society (LATS)...
  48. ncbi Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Cisanello Hospital, Via Paradisa 2, 56124 Pisa, Italy
    Surgery 132:1114-7; discussion 1118. 2002
    ..Mean thyroid volume was 64 mL (range, 10-145 mL)...
  49. ncbi Adjuvant effect of lithium on radioiodine treatment of hyperthyroidism
    Fausto Bogazzi
    Thyroid 12:1153-4. 2002
  50. ncbi Editorial: glucocorticoids for Graves' ophthalmopathy: how and when
    Luigi Bartalena
    J Clin Endocrinol Metab 90:5497-9. 2005
  51. ncbi Radioiodine therapy and Graves' ophthalmopathy
    Luigi Bartalena
    Nucl Med Commun 23:1143-5. 2002
  52. ncbi Orbital decompression in graves' ophthalmopathy by medial and lateral wall removal
    Stefano Sellari-Franceschini
    Department of Neuroscience, Ia ENT division, Pisa, Italy
    Otolaryngol Head Neck Surg 133:185-9. 2005
    ..The objective of this study is to describe a technique for balanced orbital decompression and to analyze the results...
  53. ncbi Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
    Clin Endocrinol (Oxf) 67:533-7. 2007
    ..Type 2 AIT is a destructive thyroiditis, responds to glucocorticoids, and usually does not require further thyroid treatment once euthyroidism has been restored...
  54. ncbi Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Italy
    J Clin Endocrinol Metab 88:1999-2002. 2003
    ..221 +/- 111 d, respectively, P < 0.002). This study shows that, albeit both drugs are effective, glucocorticoids are probably the drug of choice for more rapidly curing type II AIT...
  55. ncbi Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet?
    Luigi Bartalena
    J Clin Endocrinol Metab 89:5908-9. 2004
  56. ncbi Orbital radiotherapy for Graves' ophthalmopathy
    Luigi Bartalena
    J Clin Endocrinol Metab 89:13-4. 2004
  57. ncbi Epidemiology and prevention of Graves' ophthalmopathy
    Wilmar M Wiersinga
    Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Thyroid 12:855-60. 2002
    ..Smoking withdrawal may increase the effectiveness of immunosuppressive treatment...
  58. ncbi Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
    J Clin Endocrinol Metab 87:2403-6. 2002
    ..03). In conclusion, patients with active Acro have a reduced expression of PPARgamma in the colonic mucosa, which appears be related to the increased serum IGF-I levels and might lead to an increased prevalence of colonic polyps...
  59. ncbi Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
    Thyroid 16:989-95. 2006
    ..Thyrotropin (TSH)-secreting pituitary adenoma (TSHoma) and resistance to thyroid hormone (RTH) are two forms of inappropriate TSH secretion. Thyroid blood flow is largely TSH dependent...
  60. ncbi Apoptosis is reduced in the colonic mucosa of patients with acromegaly
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
    Clin Endocrinol (Oxf) 63:683-8. 2005
    ..GH and IGF-1 decrease apoptosis in several cell lines including human colonic adenocarcinoma, but it is unknown whether epithelial cells of colonic mucosa of patients with acromegaly have reduced apoptosis...
  61. ncbi Smoking and Graves' disease
    Luigi Bartalena
    J Endocrinol Invest 25:402. 2002
  62. doi Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study
    Armando Bartolazzi
    Department of Pathology, St Andrea University Hospital, Rome, Italy
    Lancet Oncol 9:543-9. 2008
    ..We aimed to assess the diagnostic effect of galectin-3 expression analysis in distinguishing preoperatively benign from malignant follicular thyroid nodules when FNA findings were indeterminate...
  63. ncbi Orbital radiation therapy for Graves' ophthalmopathy
    Luigi Bartalena
    Ophthalmology 110:452-3; author reply 453-4. 2003
  64. ncbi Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH
    Fausto Bogazzi
    Department of Endocrinology and Metabolism, University of Pisa, Ospedale Cisanello, Via Paradisa 2, 56124 Pisa, Italy
    J Endocrinol 194:521-7. 2007
    ..This study demonstrated a direct effect of GH on key proteins involved in energy metabolism of acromegalic hearts...
  65. ncbi Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy
    Michele Marino
    Thyroid 14:403-6. 2004
  66. ncbi Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases
    Luca Manetti
    Dipartimento di Endocrinologia, Universita di Pisa, Ospedale Cisanello, Via Paradisa, 2, Pisa, Italy
    J Clin Endocrinol Metab 92:2176-81. 2007
    ..Circulating antipituitary antibodies (APA) are markers of autoimmune hypophysitis, which may cause deficient pituitary function. The prevalence of APA in autoimmune thyroid disorders (AITD) is uncertain...